Page last updated: 2024-10-24

candesartan and Pemphigus

candesartan has been researched along with Pemphigus in 2 studies

candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.

Pemphigus: Group of chronic blistering diseases characterized histologically by ACANTHOLYSIS and blister formation within the EPIDERMIS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saito, Y1
Hayashi, S1
Yamauchi, A1
Okamoto, M1
Kaminaga, T1
Hamasaki, Y1
Hatamochi, A1
Igawa, K1
Bae, YI1
Yun, SJ1
Lee, SC1
Park, GT1
Lee, JB1

Reviews

1 review available for candesartan and Pemphigus

ArticleYear
Tracing the origins of active amide group-positive drug-induced pemphigus vulgaris along the Silk Road: a case report of candesartan-induced pemphigus vulgaris and review of nonthiol drug-induced pemphigus.
    International journal of dermatology, 2018, Volume: 57, Issue:11

    Topics: Aged; Amides; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Humans; Male; Pemphigus;

2018

Other Studies

1 other study available for candesartan and Pemphigus

ArticleYear
Pemphigus foliaceus induced by an angiotensin II receptor blocker.
    Clinical and experimental dermatology, 2008, Volume: 33, Issue:6

    Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Biphenyl Compounds; Female

2008